Bordetella pertussis RNA Detection Qualitative Test
At DNA Labs UAE, we offer the Bordetella pertussis RNA Detection Qualitative Test to diagnose whooping cough. This test detects the presence of Bordetella pertussis, the bacteria responsible for causing this contagious respiratory infection.
Test Details
The Bordetella pertussis RNA detection qualitative test is a diagnostic tool used to detect the presence of Bordetella pertussis, the bacteria responsible for causing whooping cough. This test is based on the detection of the bacteria’s RNA, which is a genetic material specific to Bordetella pertussis.
The test involves collecting a respiratory specimen, usually obtained through a nasopharyngeal swab or cough plate, from the patient suspected of having whooping cough. The collected specimen is then processed in our laboratory, where the RNA is extracted and purified.
The extracted RNA is then subjected to a molecular technique called reverse transcription polymerase chain reaction (RT-PCR). In this technique, the RNA is converted into complementary DNA (cDNA) using reverse transcriptase enzyme. The cDNA is then amplified using PCR, which generates millions of copies of the specific target sequence of the Bordetella pertussis RNA.
To detect the amplified DNA, various methods can be used, such as fluorescent probes or DNA sequencing. These methods allow the identification of the specific DNA sequence that is unique to Bordetella pertussis. If the target DNA sequence is detected, it indicates the presence of Bordetella pertussis in the patient’s respiratory specimen, confirming the diagnosis of whooping cough.
The Bordetella pertussis RNA detection qualitative test is highly sensitive and specific, providing rapid and accurate results. It is commonly used in clinical laboratories to diagnose whooping cough and guide appropriate treatment. Early detection of Bordetella pertussis is crucial for timely intervention and preventing the spread of the disease.
Test Information
- Test Name: Bordetella pertussis RNA Detection Qualitative Test
- Components: Nasopharyngeal secretions, swabs, Oral/rectal swabs and necropsy samples. Blood, Urine, Sputum, throat swab, and bronchoalveolar lavage samples, lung tissue, etc.
- Price: 1160.0 AED
- Report Delivery: 4th Working Day Email: 48 hours. On phone: 36 hours
- Method: Real Time PCR
- Test Type: Viral
- Doctor: Physician
- Test Department: Genetics
- Pre Test Information: Need to sign Consent document and bring any clinical history of patient for Bordetella pertussis (RNA Detection) Qualitative Test
Don’t wait, get tested for whooping cough today at DNA Labs UAE. Our Bordetella pertussis RNA Detection Qualitative Test is reliable, accurate, and affordable. Contact us to schedule an appointment or for more information.
| Test Name | Bordetella pertussis RNA Detection Qualitative Test |
|---|---|
| Components | |
| Price | 1160.0 AED |
| Sample Condition | Nasopharyngeal secretions, swabs, Oral\/rectal swabs and necropsy samples. Blood,Urine, Sputum, throat swab, and bronchoalveolar lavage samples, lung tissue,etc. |
| Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
| Method | Real Time PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forBordetella pertussis (RNA Detection) QualitativeTest |
| Test Details | The Bordetella pertussis RNA detection qualitative test is a diagnostic tool used to detect the presence of Bordetella pertussis, the bacteria responsible for causing whooping cough. This test is based on the detection of the bacteria’s RNA, which is a genetic material specific to Bordetella pertussis. The test involves collecting a respiratory specimen, usually obtained through a nasopharyngeal swab or cough plate, from the patient suspected of having whooping cough. The collected specimen is then processed in a laboratory, where the RNA is extracted and purified. The extracted RNA is then subjected to a molecular technique called reverse transcription polymerase chain reaction (RT-PCR). In this technique, the RNA is converted into complementary DNA (cDNA) using reverse transcriptase enzyme. The cDNA is then amplified using PCR, which generates millions of copies of the specific target sequence of the Bordetella pertussis RNA. To detect the amplified DNA, various methods can be used, such as fluorescent probes or DNA sequencing. These methods allow the identification of the specific DNA sequence that is unique to Bordetella pertussis. If the target DNA sequence is detected, it indicates the presence of Bordetella pertussis in the patient’s respiratory specimen, confirming the diagnosis of whooping cough. The Bordetella pertussis RNA detection qualitative test is highly sensitive and specific, providing rapid and accurate results. It is commonly used in clinical laboratories to diagnose whooping cough and guide appropriate treatment. Early detection of Bordetella pertussis is crucial for timely intervention and preventing the spread of the disease. |
